Trial intelligence / Profile preview

Comparison of two remifentanil dosages via patient-controlled sedation/analgesia (PCSA) for endoscopic procedures

2009-010383-42Phase 4Completed

Sponsor
IRCCS Ospedale San Raffaele
Start
Mar 2009
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4 trial of remifentanil in esophagogastroduodenoscopy (2 arms), sponsored by IRCCS Ospedale San Raffaele. Primary endpoint: Patient satisfaction. Started Mar 2009; status: completed.

02

Drugs

remifentanil
03

Conditions

esophagogastroduodenoscopy

Beyond the preview

Go deeper on 2009-010383-42.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-010383-42.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call